Clinical Trials
4 trialsNCT04629729 2026-03-19
FT819 in Subjects With B-cell Malignancies
Fate Therapeutics
Phase 1 Active not recruiting
NCT03991884 2023-07-06
Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia
University of Washington
Phase 1 Completed
NCT01786135 2017-10-19
A Safety Study of SGN-CD19A for B-Cell Lymphoma
Seagen Inc.
Phase 1 Completed
NCT01786096 2017-07-02
A Safety Study of SGN-CD19A for Leukemia and Lymphoma
Seagen Inc.
Phase 1 Completed